Description

Tirzepatide is a synthetic peptide designed to engage both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways. These signalling systems are widely studied in nutrient handling, glucose regulation and energy-balance research.

MMRR Tirzepatide is listed as a research material. Vial size and pricing will be added to the catalogue when finalized. Every MMRR batch is independently third-party tested under the MMRR testing program.

Manufactured in Atlantic Canada. For research purposes only. No dosing or medical-use guidance is provided.

Additional information

Size	10 mg, 20 mg

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Independent third-party testing

Every MMRR product batch is independently tested by a third-party laboratory before release. Core analytical testing is designed to confirm identity, chromatographic purity and peptide content, with additional impurity, moisture, residual-solvent, elemental and microbiological testing used where applicable to the product and batch.

Testing is product- and batch-specific. MMRR does not treat a purity percentage as a substitute for identity, content or microbiological testing.

Read about MMRR testing ↗